Sirolimus prevents short-term renal changes induced by ischemia-reperfusion injury in rats

American Journal of Nephrology

Volumn 33, Issue 3, 2011, Pages 239-249

  Esposito, C ^a   Grosjean, F ^a   Torreggiani, M ^a   Esposito, V ^a   Mangione, F ^a   Villa, L ^a   Sileno, G ^a   Rosso, R ^a   Serpieri, N ^a   Molinaro, M ^a   Fasoli, G ^a   Dal Canton, A ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Immunosuppressive drugs; Ischemia reperfusion injury; Metalloprotease activity

Indexed keywords

BETA ACTIN; CALCINEURIN INHIBITOR; CYCLOSPORIN; FIBRONECTIN; RAPAMYCIN; SODIUM CHLORIDE; TACROLIMUS; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INULIN CLEARANCE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY ISCHEMIA REPERFUSION INJURY; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIROLIMUS; TACROLIMUS;

EID: 79952058947     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324577     Document Type: Article

References (29)

1. Ojo AO, Wolfe RA, Held P, Port FK, Schmouder RL: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968-974. (Pubitemid 27173019)
2. Schrier RW, Wang W, Poole B, Mitra A: Acute renal failure definitions, diagnosis, pathogenesis and therapy. J Clin Invest 2004; 114: 5-14. (Pubitemid 39071636)
3. Bonventre JV, Zuk A: Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004; 66: 480-485. (Pubitemid 38981982)
4. Solez K, Morel-Maroger L, Sraer JD: The morphology of acute tubular necrosis in man: analysis of 57 renal biopsies and a com-parison with the glycerol model. Medicine (Baltimore) 1979; 58: 362-376. (Pubitemid 10234879)
5. Savransky V, Molls RR, Burne-Taney M, Chien C-C, Racusen L, Rabb H: Role of T-cell receptor in kidney ischemia-reperfusion in-jury. Kidney Int 2006; 69: 233-238. (Pubitemid 43323072)
6. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NT: Cellular and molecular pre-dictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a sin-gle kidney. Transplantation 1997; 64: 190-197. (Pubitemid 27332657)
7. Shoskes DA, Cecka M: Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697-1701. (Pubitemid 29034994)
8. Conte G, Dal Canton A, Sabbatini M, Napo-dano P, De Nicola L, Gigliotti G, Fuiano G, Testa A, Esposito C, Russo D, Andreucci VE: Acute cyclosporine renal dysfunction re-versed by dopamine infusion in healthy sub-jects. Kidney Int 1989; 36: 1086-1092. (Pubitemid 20049216)
9. Esposito C, Fornoni A, Cornacchia F, Bel-lotti N, Fasoli G, Foschi A, Mazzuccchelli I, Mazzullo T, Semeraro L, Dal Canton A: Cy-closporine induces different responses in human endothelial, epithelial and fibro-blast cell cultures. Kidney Int 2000; 58: 123-131.
10. Kreis H, Oberbauer R, Campistol M, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF: Long term benefits with sirolimus based therapy after early cyclosporine withdrawal. J Am Soc Nephrol 2004; 15: 809-817. (Pubitemid 38294812)
11. Coombes JD, Mreich E, Liddle C, Rangan GK: Rapamycin worsen renal function and intratubular cast formation in protein over-load nephropathy. Kidney Int 2005; 68: 2599-2607. (Pubitemid 43251006)
12. Goncalves GM, Cenedeze MA, Feitoza CQ, de Paula CB, Marques GD, Pinheiro HS, de Paula Antunes Teixeira V, dos Reis MA, Pa-checo-Silva A, Camara NOS: The role of im-munosuppressive drugs in aggravating renal ischemia and reperfusion injury. Transpl Proc 2007; 39: 417-420. (Pubitemid 46386247)
13. Dal Canton A, Conte G, Esposito C, Guasco R Russo D, Sabbatini M, Uccello F, An-dreucci VE: Effects of pregnancy on glomer-ular dynamics: micropuncture study in the rat. Kidney Int 1982; 22: 608-612. (Pubitemid 13204104)
14. Esposito C, Parrilla B, Cornacchia F, Gros-jean F, Mangione F, Serpieri N, Valentino R, Villa L, Arra M, Esposito V, Dal Canton A: The antifibrogenic effect of hepatocyte growth factor (HGF) on renal tubular (HK-2) cells is dependent on cell growth. Growth Factors 2009; 27: 1-8.
15. Esposito C, Parrilla B, De Mauri A, Cornac-chia F, Fasoli G, Foschi A, Mazzullo T, Plati AR, Scudellaro R, Dal Canton A: Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int 2005; 67: 2143-2150. (Pubitemid 41630368)
16. Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK: Macrophages contribute to the development of renal fibrosis following ischaemia/reper-fusion-induced acute kidney injury. Nephrol Dial Transplant 2008; 23: 842-852. (Pubitemid 351767562)
17. Singh D, Chander V, Chopra K: Cyclosporine protects against ischemia/reperfusion injury in rat kidneys. Toxicology 2005; 207: 339-347. (Pubitemid 40138931)
18. Saurina A, Campistol JM, Piera C, Diek-mann F, Campos B, Campos N, de la Cuevas X, Oppenheimer F: Conversion from calci-neurin inhibitors to sirolimus in chronic al-lograft dysfunction: changes in glomerular haemodynamics and proteinuria. Nephrol Dial Transplant 2006; 21: 488-493. (Pubitemid 43160007)
19. Sindhi R, Webber S, Venkataramanan R, McGhee W, Phillips S, Smith A, Baird C, Iur-lano K, Mazariengos G, Cooperstone B, Holt DW, Zeevi A, Fung JJ, Reyes J: Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001; 72: 851-855. (Pubitemid 32879857)
20. Johnson RW, Kreis H, Oberbauer R, Bratt-strom C, Claesson K, Eris J: Sirolimus allow early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Trans-plantation 2001; 72: 777-786. (Pubitemid 32879845)
21. Halloran PF: Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351: 2715-2729. (Pubitemid 39665325)
22. Simon JF, Swanson SJ, Agodoa LY, Cruess DF, Bohen EM, Abbott KC: Induction siroli-mus and delayed graft function after de-ceased donor kidney transplantation in the United States. Am J Nephrol 2004; 24: 393-401. (Pubitemid 39279380)
23. Lui SL, Chan KW, Tsang R, Yung S, Lai KN, Chan TM: Effect of rapamycin on renal isch-emia-reperfusion injury in mice. Transpl Int 2006; 19: 834-839. (Pubitemid 44358851)
24. Inman SR, Davis NA, Olson KM, Lukaszek VA, McKinley MR, Seminerio JL: Rapamy-cin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury. Urology 2003; 62: 750-754. (Pubitemid 37205027)
25. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU: Mycopheno-late mofetil/sirolimus compared to other common immunosuppressive regimen in kidney transplantation. Am J Transplant 2007; 7: 586-594. (Pubitemid 46376441)
26. Furian L, Baldan N, Margani G, Ekser B, Sil-vestre C, Marchini F, Bonfante L, Rossi B, Valente ML, Rigotti P: Calcineurin inhibi-tor-free immunosuppression in dual kidney transplantation from elderly donors. Clin Transplant 2007; 21: 57-62. (Pubitemid 46189588)
27. Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrancois N, Charpen-tier B, Blanc AS, Di Giambattista F, Dantal J, RAD A2420 Study Group: Incidence of de-layed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus. Transplantation 2009; 15: 69-76.
28. Akool ES, Doller A, Babelova A, Tsalastra W, Moreth K, Schaefer L, Pfeilschifter J, Eber-hardt W: Molecular mechanisms of TGFß receptor-triggered signaling cascades rapid-ly induced by the calcineurin inhibitors cy-closporine A and FK506. J Immunol 2008; 181: 2831-2845.
29. Ronco P, Chatziantoniou C: Matrix metal-loproteinases and matrix receptors in pro-gression and reversal of kidney disease: ther-apeutic perspectives. Kidney Int 2008; 74: 873-878.